skip to contentNational Cancer Institute
National Cancer Institute U.S. National Institutes of Health www.cancer.gov
Found 105 results for your search:
Relevant funding data is only available when one cancer type or one research topic is selected.
Fiscal Year FY 2012
NIH Funding Mechanism [K08]
Modify this Search New Search
Close

Modify Search Criteria

Some search criteria may be modified to refine your current search.

Select criteria to modify:

Add or remove search options:

Select criteria above to see additional search options

Cancel
Showing 1 - 50 of 105 results
Clipboard
Project Title Sorted ascending Project Number Funded Amount Principal
Investigator
Institution
1
"Comparative gene resequencing in mouse cancer models" 5K08CA160658-02 $180,360 McFadden, David MASSACHUSETTS GENERAL HOSPITAL
2
A Model for Preclinical Biomarker Discovery in Pancreatic Ductal Adenocarcinoma 5K08CA137153-03 $163,080 Collisson, Eric UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
3
A Novel sequencing-based approach to discovering rare genetic factors for ALL. 5K08CA140720-03 $149,387 Druley, Todd WASHINGTON UNIVERSITY
4
Aberrant activation of HGF/MET signaling as a therapeutic target in AML 5K08CA160660-02 $156,330 Kentsis, Alex DANA-FARBER CANCER INSTITUTE
5
An Integrated Approach to the Validation of Novel Gastric Cancer Oncogenes 1K08CA166512-01 $147,086 Nadauld, Lincoln STANFORD UNIVERSITY
6
Analysis of the leukemic stem cell niche in chronic myeloid leukemia 5K08CA138916-03 $162,568 Krause, Daniela MASSACHUSETTS GENERAL HOSPITAL
7
Antibody directed delivery of short interfering RNA for the treatment of ovarian 1K08CA163603-01A1 $170,631 PALANCA-WESSELS, MARIA FRED HUTCHINSON CANCER RESEARCH CENTER
8
Assessing the Notch Pathway as a Therapeutic Target in Lung Cancer Adenocarcinoma 5K08CA158425-02 $174,800 Hassan, Khaled UNIVERSITY OF MICHIGAN AT ANN ARBOR
9
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer 1K08CA163941-01 $173,772 Moon, Edmund UNIVERSITY OF PENNSYLVANIA
10
Autophagy and apoptosis in the response of c-KIT cancers to targeted therapy 5K08CA154782-02 $143,362 GORDON, PETER CHILDREN'S HOSPITAL BOSTON
11
Axl receptor signaling in MPNST; potential node for therapy 1K08CA160443-01A1 $170,618 TORRES, KEILA UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
12
Biologic and therapeutic implications of Akt activation in Her2+ breast cancer 5K08CA134833-04 $145,152 Chandarlapaty, Sarat SLOAN-KETTERING INSTITUTE FOR CANCER RES
13
Bombesin-Activated Carcinoma Associated Fibroblasts in Colorectal Cancer 5K08CA125209-04 $128,507 CHAO, CELIA UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
14
cAMP signaling in melanoma pathogenesis: Evidence for multiple microdomains playi 5K08CA160657-02 $171,180 Zippin, Jonathan WEILL MEDICAL COLLEGE OF CORNELL UNIV
15
CD40 Pathway in Pancreatic Adenocarcinoma 5K08CA138907-02 $162,462 Beatty, Gregory UNIVERSITY OF PENNSYLVANIA
16
Combined Pre & Intraoperative Brain Tumor Imaging Strategy using a Dual-Modality 1K08CA163961-01A1 $178,740 Kircher, Moritz SLOAN-KETTERING INSTITUTE FOR CANCER RES
17
Defining the role of macrophages in the progression of human cutaneous squamous c 1K08CA172580-01 $148,492 Colegio, Oscar YALE UNIVERSITY
18
Designer antigen receptors to re-direct T cells to the NY-ESO-1 tumor antigen 1K08CA166039-01 $149,472 Maus, Marcela UNIVERSITY OF PENNSYLVANIA
19
Dissection of microRNA-21s role in non-small cell lung cancer 5K08CA151649-03 $168,480 Hatley, Mark ST. JUDE CHILDREN'S RESEARCH HOSPITAL
20
Effects of diacylglycerol kinase zeta deficiency on CD8+ T cell function 7K08CA151893-03 $171,180 Riese, Matthew MEDICAL COLLEGE OF WISCONSIN
21
EGFR signaling and normal and tumor-derived neural stem cell behavior 5K08CA130985-05 $136,890 BOOCKVAR, JOHN WEILL MEDICAL COLLEGE OF CORNELL UNIV
22
Elucidating the Role of Akt and Keratins in Autophagy and Tumorigenesis 1K08CA164047-01A1 $143,312 Wang, Richard UNIV OF TX SW MED CTR-DALLAS
23
Elucidating the roles of ETV1 in the pathogenesis of GIST 5K08CA151660-02 $169,589 Chi, Ping SLOAN-KETTERING INSTITUTE FOR CANCER RES
24
Epigenetic Mechanisms of Lymphomagenesis. 5K08CA127353-05 $138,672 Shaknovich, Rita WEILL MEDICAL COLLEGE OF CORNELL UNIV
25
EPIMORPHIN DELETION ALTERS STEM CELL NICHE MYOFIBROBLAST SECRETION 5K08CA153036-02 $161,511 Shaker, Anisa WASHINGTON UNIVERSITY
26
Exploring synergy of combined BRAF-targeted therapy & immunotherapy for melanoma 1K08CA160692-01A1 $142,560 Wargo, Jennifer MASSACHUSETTS GENERAL HOSPITAL
27
Ezh2 in MLL-AF9 mediated acute myeloid leukemia 5K08CA154777-02 $146,016 Neff, Tobias CHILDREN'S HOSPITAL BOSTON
28
Feedback regulation and functional output of the RAS/RAF/MEK/MAPK pathway in huma 5K08CA127350-04 $173,232 Pratilas, Christine SLOAN-KETTERING INSTITUTE FOR CANCER RES
29
Genetic and epigenetic basis of relapse in acute myeloid leukemia 1K08CA169055-01 $148,320 Garrett-Bakelman, Francine WEILL MEDICAL COLLEGE OF CORNELL UNIV
30
Genetic and Proteomic Analysis of Epstein-Barr Virus LMP1 Activation of NF-kB 5K08CA140780-03 $179,910 Gewurz, Benjamin BRIGHAM AND WOMEN'S HOSPITAL
31
Genetic Association Studies in African American Colorectal Cancer Patients 5K08CA142892-03 $164,376 Kupfer, Sonia UNIVERSITY OF CHICAGO
32
Genetic Modifiers such as Fas Regulate Tumor-Cell Dependence on Mutant EGFR 5K08CA154787-02 $168,480 Bivona, Trever UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
33
Genome Discovery and Validation in Upper Gastrointestinal Carcinomas 5K08CA134931-05 $140,940 Bass, Adam DANA-FARBER CANCER INSTITUTE
34
Genome-wide promoter methylation profiling of glioma 5K08CA124479-05 $136,500 LAI, ALBERT UNIVERSITY OF CALIFORNIA AT LOS ANGELES
35
Genomic Discovery and Targeted Therapeutics in Squamous Cell Lung Cancer 1K08CA163677-01A1 $177,120 Hammerman, Peter DANA-FARBER CANCER INSTITUTE
36
High-throughput Analysis of Mutations Identified by RNA-sequencing Triple Negativ 1K08CA148912-01A1 $151,842 Stricker, Thomas VANDERBILT UNIVERSITY MED CTR
37
Immunosuppressive Network of Human Hepatocellular Carcinoma 5K08CA151414-03 $174,960 Welling, Theodore UNIVERSITY OF MICHIGAN AT ANN ARBOR
38
Innovative Delivery Strategy for CaSm Gene Therapy in Pancreatic Cancer 5K08CA142904-03 $173,448 Camp, Ernest MEDICAL UNIVERSITY OF SOUTH CAROLINA
39
Integrated analysis of Notch pathway loss-of-function in epithelial tumorigenesis 1K08CA169865-01 $126,090 Cho, Raymond UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
40
Investigating the role of retrotransposons in hematopoietic neoplasias. 5K08CA134746-05 $141,345 BURNS, KATHLEEN JOHNS HOPKINS UNIVERSITY
41
Linking histone demethylation and the DNA damage response. 7K08CA158133-02 $156,685 MOSAMMAPARAST, NIMA WASHINGTON UNIVERSITY
42
Mechanism of Acquired Resistance to VEGF-R Antagonists in RCC 5K08CA138900-03 $169,560 BHATT, RUPAL BETH ISRAEL DEACONESS MEDICAL CENTER
43
Mechanism of Radiation Mediated Clearance of HPV Positive Head and Neck Cancer 5K08CA149078-02 $154,360 Spanos, William SANFORD RESEARCH/USD
44
Mechanisms of bHLH Mediated Lineage Specification 1K08CA169014-01 $158,910 Fong, Abraham FRED HUTCHINSON CANCER RESEARCH CENTER
45
Mechanisms of Bortezomib-induced Peripheral Neuropathy 1K08CA169443-01 $144,396 Staff, Nathan MAYO CLINIC
46
Mechanisms of invariant NKT cell-mediated in vivo anti-tumor responses 1K08CA166184-01 $135,351 Bassiri, Hamid CHILDRENS HOSPITAL OF PHILADELPHIA
47
Metabolic contribution to cell viability and therapy resistance in the acute 1K08CA169809-01 $167,980 Pardee, Timothy WAKE FOREST UNIVERSITY HEALTH SCIENCES
48
Metabolic roles for Lin28-let-7 miRNA pathway in sarcoma tumorigenesis 5K08CA157727-02 $174,410 ZHU, HAO CHILDREN'S HOSPITAL BOSTON
49
MicroRNA-200 family regulation by the apical-basal polarity complexes in EMT and 5K08CA151651-03 $170,640 Gibbons, Don UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
50
Modifying The Risk For Developing Triple Negative Breast Cancer (TNBC) 1K08CA172722-01 $172,260 Omene, Coral NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Relevant funding data is only available when one cancer type or one research topic is selected.
Showing 1 - 50 of 105 results
Go to top